Clinically, type 1 diabetes (T1DM) and advanced type 2 diabetes (T2DM) patients require multiple daily insulin injections to maintain blood glucose levels, which may cause great pain and is an inconvenience to patients and can lead to hyperinsulinemia. In comparison, oral insulin therapy has high patient compliance.
Click here for original story, Viral surface-inspired nanocarriers for improved oral insulin therapy
Source: Phys.org